Sergio Ramos to PSG CONFIRMED, Messi contract LATEST, Tottenham ‘battle Barcelona for Insigne’, Chelsea transfer news


England have made it to the Euro 2020 final after beating Denmark at Wembley.

The Danes opened the scoring with Mikkel Damsgaard’s incredible free-kick on 30 minutes.

But the Three Lions equalised just nine minutes later thanks to an own goal by Simon Kjaer.

The game went to extra-time where Gareth Southgate’s side earned a controversial penalty when Raheem Sterling went down inside the area.

Harry Kane took the spot-kick but Kasper Schmeichel saved low at his bottom left corner.

The ball rolled back towards Kane who sent it to the back of the net in the 14th minute of extra-time.

England are going to face Italy this Sunday at Wembley.

Meanwhile, Chelsea have missed out on transfer target Achraf Hakimi, who stood out last year with Inter Milan.

Hakimi has officially joined Paris Saint-Germain, following an official statement from the club.

The highly-rated full-back put pen to paper on a five-year deal to complete his third transfer in three years.

PSG agreed a £59million fee with Inter last month after the Serie A champions rejected a bid from the Blues.

Manchester United, Arsenal and Chelsea have also been dealt a transfer blow amid their interest in former Real Madrid captain Sergio Ramos.

That is according to The Guardian, who claim Ramos is set to undergo a medical with PSG.

The Spain international left Real after 16 trophy-laden years when his contract expired.

And the 35-year-old star centre-back is now set to sign a two-year deal with the Parisians.

And Arsenal are close to landing Anderlecht ace Albert Sambi Lokonga.

See also  Man City boss Pep Guardiola rues slow start in FA Cup semi-final defeat by Arsenal

That is according to transfer expert Fabrizio Romano, who claims the final details will be sorted soon.

Negotiations are at a final stage, which means that a medical has not been scheduled yet.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more